Forte Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
FBRX Nasdaq 2836 www.fortebiorx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Forte Biosciences, Inc.

Forte Biosciences to Host R&D Day December 3, 2024 - Nov 25th, 2024 2:00 pm
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications - Nov 20th, 2024 2:00 pm
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update - Nov 14th, 2024 9:01 pm
Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested - Aug 26th, 2024 3:51 pm
Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update - Aug 14th, 2024 8:01 pm
Companies Like Forte Biosciences (NASDAQ:FBRX) Could Be Quite Risky - May 21st, 2024 10:28 am
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - May 17th, 2024 8:05 pm
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update - May 13th, 2024 8:05 pm
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update - Mar 18th, 2024 8:05 pm